319 related articles for article (PubMed ID: 26892651)
1. Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):411-20; quiz 421-2. PubMed ID: 26892651
[TBL] [Abstract][Full Text] [Related]
2. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
3. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
4. Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ; Jaju PD; Tang JY; Carbone M; Leachman S; Sarin KY
J Am Acad Dermatol; 2016 Mar; 74(3):423-34; quiz 435-6. PubMed ID: 26892652
[TBL] [Abstract][Full Text] [Related]
5. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
[TBL] [Abstract][Full Text] [Related]
6. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
7. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T; Mæhle L
Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
[TBL] [Abstract][Full Text] [Related]
8. BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy.
Soares de Sá BC; de Macedo MP; Torrezan GT; Braga JCT; Fidalgo F; Moredo LF; Lellis R; Duprat JP; Carraro DM
BMC Cancer; 2019 Nov; 19(1):1077. PubMed ID: 31706282
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer Associated Genodermatoses: A Literature Review.
Schierbeck J; Vestergaard T; Bygum A
Acta Derm Venereol; 2019 Apr; 99(4):360-369. PubMed ID: 30653245
[TBL] [Abstract][Full Text] [Related]
10. A questionnaire survey of Midwest dermatologists on the clinical-genetic aspects of patients with multiple atypical nevi.
Fusaro RM; Johnsen LR; Hoden RH; Lynch HT
Nebr Med J; 1993 May; 78(5):132-7. PubMed ID: 8316319
[TBL] [Abstract][Full Text] [Related]
11. CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic study.
De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Stanganelli I; Palmieri G; Massi D
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):574-80. PubMed ID: 25200134
[TBL] [Abstract][Full Text] [Related]
12. Familial melanoma and multiple primary melanoma.
DE Simone P; Valiante M; Silipo V
G Ital Dermatol Venereol; 2017 Jun; 152(3):262-265. PubMed ID: 28121081
[TBL] [Abstract][Full Text] [Related]
13. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
14. Melanoma susceptibility genes and risk assessment.
Marzuka-Alcalá A; Gabree MJ; Tsao H
Methods Mol Biol; 2014; 1102():381-93. PubMed ID: 24258989
[TBL] [Abstract][Full Text] [Related]
15. German national case collection of familial pancreatic cancer - clinical-genetic analysis of the first 21 families.
Rieder H; Sina-Frey M; Ziegler A; Hahn SA; Przypadlo E; Kress R; Gerdes B; Colombo Benkmann M; Eberl T; Grützmann R; Lörken M; Schmidt J; Bartsch DK
Onkologie; 2002 Jun; 25(3):262-6. PubMed ID: 12119461
[TBL] [Abstract][Full Text] [Related]
16. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
[TBL] [Abstract][Full Text] [Related]
17. Hereditary melanoma.
Bonadies DC; Bale AE
Curr Probl Cancer; 2011; 35(4):162-72. PubMed ID: 21911180
[No Abstract] [Full Text] [Related]
18. Familial melanoma; CDKN2A and beyond.
Gruis NA; van der Velden PA; Bergman W; Frants RR
J Investig Dermatol Symp Proc; 1999 Sep; 4(1):50-4. PubMed ID: 10537008
[TBL] [Abstract][Full Text] [Related]
19. Melanoma genetics.
Read J; Wadt KA; Hayward NK
J Med Genet; 2016 Jan; 53(1):1-14. PubMed ID: 26337759
[TBL] [Abstract][Full Text] [Related]
20. Hereditary cancer syndromes of the skin.
Somoano B; Niendorf KB; Tsao H
Clin Dermatol; 2005; 23(1):85-106. PubMed ID: 15708293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]